Medical device and MedTech insights, news, tips and more

Terumo, Xenex Ink Japanese Distro Deal for LightStrike Room Disinfection Robot

January 6, 2017

Xenex

Xenex

Terumo Corp. (TYO:4543) said today it inked a Japanese distribution deal with Xenex to distribute its Xenex LightStrike Germ-Zapping Robots in the region.

The LightStrike device is designed to use pulsed xenon ultraviolet room disinfection technology to remove pathogens such as C. diff, staphylococcus aureus and carbapenem-resistent Enterobacteriaceae, Terumo said. The Xenex LightStrike device has also been shown to be effective against Ebola and Anthrax, the company added.

“We have carefully analyzed the room disinfection industry and evaluated the various technologies that are being used to combat HAIs. In Xenex, we found an environmentally-friendly and evidence-based UV technology that has been shown to reduce hospital infection rates in multiple peer-reviewed published outcome studies, and this is why we have partnered with Xenex. We are dedicated to combatting infections, as evidenced by being the first company to launch disposable syringes in Japan. Helping hospitals bring down their infection rates is our goal, and we are confident that the Xenex LightStrike system will enable hospitals in Japan to reach this goal,” Terumo general hospital products division prez Tsuyoshi Tomita said in a press release.

The full room disinfection process with the germ fighting robot takes 5 minutes, the company said, and studies have shown a 50 to 100% decrease in MRSA, C.diff and surgical site infection rates after use. The device can disinfect between 30-62 rooms a day, the company said, including patient, operating, equipment, emergency, intensive care and public spaces.

Read Full Article – Source: Terumo, Xenex ink Japanese distro deal for LightStrike room disinfection robot – MassDevice

Author – 

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.